Welcome to LifeSciences2030

Investing in the future of health.

Health is the new wealth.

We support health and life science start-ups maturing into successful companies

Our mission is to empower those entrepreneurs and scientific teams to create value and transform our approach to health care. It’s time to change the world.

Fund Focus and Facts

Pharma / Biotech / Digital Health / Med Tech

Seed to Later Stage

DACH / German-speaking Europe

Investment team with strong clinical, scientific and entrepreneurial backgrounds

International and highly experienced network

Digital Health & Med Tech
LSF2030 60%
  • Apps & platforms
  • Health empowerment concepts
  • Hardware
  • Virtual medicine
  • Personalized medicine
  • Al (artificial intelligence)
  • Clinical data platforms
Pharma & Biotech
LSF2030 40%
  • Oncology therapeutics & diagnostics
  • Innovative formulation platforms
  • Anti-infective drugs

Invest in health.

2019

Global Med-Tech

Valued at some $430B in 2019

2022

9% growth

Generic pharmaceuticals market was valued at about $217B in 2018 and is expected to grow to around $309B at an annual growth rate of more than 9% through 2022

2023

$1.6 trillion

Global pharmaceutical industry will be worth $1.6 trillion with a CAGR of 6%

2024

Oncology by $233B

Oncology as the no. 1 therapy will reach $233B with 12.2% CAGR. Prescription drug sales between 2019 and 2024 are projected to have a positive CAGR of 6.9% with sales expected to reach $1.18 trillion.

2025

Biotechnology at $755B

Biotechnology market size surpassed $417B in 2018 and is projected to achieve a value of $755B in 2025 at 8.3% CAGR

2026

$500B annual sales

Digital health forecasted $500B annual sales until 2026 with 20% CAGR

Be part of it!

Our Strategic Partner

Health Hub Tirol

Our mission is to empower those entrepreneurs and scientific teams to create value and transform our approach to health care. It’s time to change the world.

Homepage Health Hub Tirol

Standortagentur Tirol

Welcome to Standortagentur Tirol

Standortagentur Tirol offers professional support and advice to help you on your road to success.
Innovation, growth, location development and marketing: Standortagentur Tirol has a comprehensive range of services to assist your company or research institute with your growth or start-up projects in Tyrol and will support you in establishing regional, national and international networks. Standortagentur Tirol develops joint projects with you based on the Tyrolean skills triangle of technology, health and tourism, balancing economical and ecological, social and cultural as well as regional and global issues. Our common goal: achieving market leadership, increasing competitiveness, safeguarding existing jobs, and creating new long-term jobs.

We look forward to meeting you and supporting you with your projects.

Homepage Standortagentur Tirol

Contact us

About us

Our team has an impressive track record in industry knowledge, competition & regulatory environment, and high-level skills in financing, restructuring, growing and performance improving.

Cornelia Beier

Initiator | Founder

30 years of experience in the pharmaceutical & biotech industries (BMS, Takeda, Pharmacia, etc.)

  • Founding partner and CEO CB one Holding GmbH
  • Founding partner at leon-nanodrugs GmbH
  • Founder health2030 platform
  • Co-founder of AI-company Oncology World
  • Partner of an international CRO network
  • Founder of one of the leading pharmaceutical PR agency in Germany (Kohtes Klewes communication medical – today Ketchum PLEON GmbH)

Berthold Baurek-Karlic

Initiator | Founder

15+ years of professional investment experience, a venture capital expert, M&A deal-maker, serial entrepreneur and angel investor

  • Founder and CEO of Venionaire (Group), incl. Venionaire Investment GmbH (AIFM)
  • Founder and secretary-general of the Business Angel Institute
  • President of the European Super Angels Club
  • Expert partner of various accelerators, and partner in venture funds
  • Entrepreneur

Invest with Us!